sr 95531 has been researched along with 1,1'-diethyl-2,2'-cyanine in 1 studies
| Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (1,1'-diethyl-2,2'-cyanine) | Trials (1,1'-diethyl-2,2'-cyanine) | Recent Studies (post-2010) (1,1'-diethyl-2,2'-cyanine) |
|---|---|---|---|---|---|
| 610 | 0 | 209 | 58 | 0 | 25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosford, PS; Mifflin, SW; Ramage, AG | 1 |
1 other study(ies) available for sr 95531 and 1,1'-diethyl-2,2'-cyanine
| Article | Year |
|---|---|
5-hydroxytryptamine-mediated neurotransmission modulates spontaneous and vagal-evoked glutamate release in the nucleus of the solitary tract effect of uptake blockade.
Topics: Animals; Citalopram; Excitatory Postsynaptic Potentials; Glutamic Acid; In Vitro Techniques; Male; Miniature Postsynaptic Potentials; Neurons; Organic Anion Transporters, Sodium-Independent; Plasma Membrane Neurotransmitter Transport Proteins; Pyridazines; Quinolines; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Solitary Nucleus; Synaptic Transmission; Vagus Nerve | 2014 |